This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Ankyra Therapeutics, Inc., Howard Hughes Medical Institute. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Darrell Irvine
Introduction
Darrell Irvine is a prominent inventor based in Arlington, MA (US). He has made significant contributions to the field of immunology and biotechnology, holding a total of 2 patents. His work focuses on developing novel technologies that enhance immune responses.
Latest Patents
Irvine's latest patents include a "Nucleic Acid Nanostructure Platform for Programming Immune Stimulation" and "Fusion Polypeptides Comprising Interleukin 12 and a Metal-Hydroxide Binding Polypeptide." The latter patent provides valuable insights into fusion polypeptides that combine an immunomodulatory moiety with a metal-hydroxide binding moiety. These innovations have potential applications in various therapeutic areas.
Career Highlights
Throughout his career, Darrell Irvine has worked with esteemed organizations such as the Howard Hughes Medical Institute and Ankyra Therapeutics, Inc. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Irvine has collaborated with notable colleagues, including Eike-Christian Wamhoff and Rebecca Du. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Darrell Irvine's contributions to immunology and biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for innovative solutions in immune stimulation and therapeutic applications.